Journal of Addiction Medicine
Journal Impact IF - Analysis · Trend · Prediction · Ranking


Journal Impact IF




Journal Impact IF Trend

Related Journals

Popular Journals

Journal of Addiction Medicine

The 2019-2020 Journal Impact IF of Journal of Addiction Medicine is 3.014, which is just updated in 2020.

Journal of Addiction Medicine Impact Factor
Highest IF
Highest Journal Impact IF

The highest Journal Impact IF of Journal of Addiction Medicine is 3.014.

Lowest IF
Lowest Journal Impact IF

The lowest Journal Impact IF of Journal of Addiction Medicine is 1.705.

Total Growth Rate
IF Total Growth Rate

The total growth rate of Journal of Addiction Medicine IF is 54.5%.

Annual Growth Rate
IF Annual Growth Rate

The annual growth rate of Journal of Addiction Medicine IF is 6.1%.

Journal Impact IF Ranking

Subcategory Quartile Rank Percentile
Psychiatry and Mental Health Q2 128/506

Psychiatry and Mental Health 74%

Pharmacology (medical) Q2 85/237

Pharmacology (medical) 64%

Journal Impact IF Ranking

· In the Psychiatry and Mental Health research field, the Quartile of Journal of Addiction Medicine is Q2. Journal of Addiction Medicine has been ranked #128 over 506 related journals in the Psychiatry and Mental Health research category. The ranking percentile of Journal of Addiction Medicine is around 74% in the field of Psychiatry and Mental Health.
· In the Pharmacology (medical) research field, the Quartile of Journal of Addiction Medicine is Q2. Journal of Addiction Medicine has been ranked #85 over 237 related journals in the Pharmacology (medical) research category. The ranking percentile of Journal of Addiction Medicine is around 64% in the field of Pharmacology (medical).

Journal of Addiction Medicine Impact Factor 2020-2021 Prediction

Journal of Addiction Medicine Impact Factor Predition System

Journal of Addiction Medicine Impact Factor Prediction System is now online. You can start share your valuable insights with the community.

Predict Check All Preditions
Total Publications
Total Citations

Annual Publication Volume

Annual Citation Record

International Collaboration Trend

Cited Documents Trend

Journal Impact IF History

Year Journal Impact IF
Year Journal Impact IF
2019-2020 3.014
2018-2019 2.699
2017-2018 2.406
2016-2017 2.129
2015-2016 2.065
2014-2015 1.756
2013-2014 1.705
2012-2013 1.726
2011-2012 1.951
Journal Impact IF History

· The 2019-2020 Journal Impact IF of Journal of Addiction Medicine is 3.014
· The 2018-2019 Journal Impact IF of Journal of Addiction Medicine is 2.699
· The 2017-2018 Journal Impact IF of Journal of Addiction Medicine is 2.406
· The 2016-2017 Journal Impact IF of Journal of Addiction Medicine is 2.129
· The 2015-2016 Journal Impact IF of Journal of Addiction Medicine is 2.065
· The 2014-2015 Journal Impact IF of Journal of Addiction Medicine is 1.756
· The 2013-2014 Journal Impact IF of Journal of Addiction Medicine is 1.705
· The 2012-2013 Journal Impact IF of Journal of Addiction Medicine is 1.726
· The 2011-2012 Journal Impact IF of Journal of Addiction Medicine is 1.951

Publications Cites Dataset

Year Publications Citations
Year Publications Citations
2007 38 5
2008 31 44
2009 30 106
2010 40 166
2011 45 346
2012 52 571
2013 73 776
2014 75 1079
2015 81 1322
2016 80 1439
2017 108 1601
2018 67 1574
2019 82 2073
2020 261 2738
2021 0 269
Publications Cites Dataset

· The Journal of Addiction Medicine has published 38 reports and received 5 citations in 2007.
· The Journal of Addiction Medicine has published 31 reports and received 44 citations in 2008.
· The Journal of Addiction Medicine has published 30 reports and received 106 citations in 2009.
· The Journal of Addiction Medicine has published 40 reports and received 166 citations in 2010.
· The Journal of Addiction Medicine has published 45 reports and received 346 citations in 2011.
· The Journal of Addiction Medicine has published 52 reports and received 571 citations in 2012.
· The Journal of Addiction Medicine has published 73 reports and received 776 citations in 2013.
· The Journal of Addiction Medicine has published 75 reports and received 1079 citations in 2014.
· The Journal of Addiction Medicine has published 81 reports and received 1322 citations in 2015.
· The Journal of Addiction Medicine has published 80 reports and received 1439 citations in 2016.
· The Journal of Addiction Medicine has published 108 reports and received 1601 citations in 2017.
· The Journal of Addiction Medicine has published 67 reports and received 1574 citations in 2018.
· The Journal of Addiction Medicine has published 82 reports and received 2073 citations in 2019.
· The Journal of Addiction Medicine has published 261 reports and received 2738 citations in 2020.
· The Journal of Addiction Medicine has published 0 reports and received 269 citations in 2021.
· The total publications of Journal of Addiction Medicine is 1063.
· The total citations of Journal of Addiction Medicine is 14109.

What is Impact Factor?

The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly average number of citations of articles published in the last two years in a given journal. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factor values are often deemed to be more important, or carry more intrinsic prestige in their respective fields, than those with lower values.

Journal of Addiction Medicine | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Impact Factor of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Impact Factor are often deemed to be more important than those with lower ones. The Journal of Addiction Medicine Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the Journal of Addiction Medicine during the two preceding years (2018-2019). Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New journals, which are indexed from their first published issue, will receive an impact factor after two years of indexing; in this case, the citations to the year prior to Volume 1, and the number of articles published in the year prior to Volume 1, are known zero values. Journals that are indexed starting with a volume other than the first volume will not get an impact factor until they have been indexed for three years. Occasionally, Journal Citation Reports assigns an impact factor to new journals with less than two years of indexing, based on partial citation data. The calculation always uses two complete and known years of item counts, but for new titles one of the known counts is zero. Annuals and other irregular publications sometimes publish no items in a particular year, affecting the count. The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of Journal of Addiction Medicine.


The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI). Impact factors are calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson ISI was sold to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.


The impact factor is used to compare different journals within a certain field. The Web of Science indexes more than 11,500 science and social science journals. Journal impact factors are often used to evaluate the merit of individual articles and individual researchers. This use of impact factors was summarised by Hoeffel:

Impact Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage of already being in existence and is, therefore, a good technique for scientific evaluation. Experience has shown that in each specialty the best journals are those in which it is most difficult to have an article accepted, and these are the journals that have a high impact factor. Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of quality is widespread because it fits well with the opinion we have in each field of the best journals in our specialty....In conclusion, prestigious journals publish papers of high level. Therefore, their impact factor is high, and not the contrary.

Eugene Garfield

In brief, Impact factors may be used by:
  • Authors to decide where to submit an article for publication.
  • Libraries to make collection development decisions
  • Academic departments to assess academic productivity
  • Academic departments to make decisions on promotion and tenure.
As impact factors are a journal-level metric, rather than an article- or individual-level metric, this use is controversial. Garfield agrees with Hoeffel,but warns about the "misuse in evaluating individuals" because there is "a wide variation [of citations] from article to article within a single journal". Other things to consider about Impact Factors:
  • Many journals do not have an impact factor.
  • The impact factor cannot assess the quality of individual articles. Even if citations were evenly distributed among articles, the impact factor would only measure the interests of other researchers in an article, not its importance and usefulness.
  • Only research articles, technical notes and reviews are “citable” items. Editorials, letters, news items and meeting abstracts are “non-citable items”.
  • Only a small percentage of articles are highly cited and they are found in a small subset of journals. This small proportion accounts for a large percentage of citations.
  • Controversial papers, such as those based on fraudulent data, may be highly cited, distorting the impact factor of a journal.
  • Citation bias may exist. For example, English language resources may be favoured. Authors may cite their own work.
Moreover, informed and careful use of these impact data is essential, and should be based on a thorough understanding of the methodology used to generate impact factors. There are controversial aspects of using impact factors:
  • It is not clear whether the number of times a paper is cited measures its actual quality.
  • Some databases that calculate impact factors fail to incorporate publications including textbooks, handbooks and reference books.
  • Certain disciplines have low numbers of journals and usage. Therefore, one should only compare journals or researchers within the same discipline.
  • Review articles normally are cited more often and therefore can skew results.
  • Self-citing may also skew results.
  • Some resources used to calculate impact factors have inadequate international coverage.
  • Editorial policies can artificially inflate an impact factor.
Impact factors have often been used in advancement and tenure decision-making. Many recognize that this is a coarse tool for such important decisions, and that a multitude of factors should be taken into account in these deliberations. When considering the use of the impact factor (IF), keep these aspects in mind:
  • IF analysis is limited to citations from the journals indexed by the Web of Science/Web of Knowledge. Currently, the Web of Science indexes only 8621 journals across the full breadth of the sciences, and just 3121 in the social sciences.
  • A high IF/citation rate says nothing about the quality -- or even, validity -- of the references being cited. Notorious or even retracted articles often attract a lot of attention, hence a high number of citations. The notority related to the first publication on "cold fusion" is one such example.
  • Journals that publish more "review articles" are often found near the top of the rankings. While not known for publishing new, creative findings, these individual articles tend to be heavily cited.
  • The IF measures the average number of citations to articles in the journal -- given this, a small number of highly-cited articles will skew the figure.
  • It takes several years for new journals to be added to the list of titles indexed by the Web of Science/Web of Knowledge, so these newer titles will be under-represented.
  • It's alleged that journal editors have learned to "game" the system, encouraging authors to cite their works previously published in the same journal.
Comparing Journals Across Disciplines? Not a good idea! Using Impact Factors within a given discipline should only be done with great care, as described above. Using impact factor data to compare journals across disciplines is even more problematic. Here are some of the reasons:
  • Disciplines where older literature is still referenced, such as Chemistry and Mathematics, offer challenges to the methodolgy since older citations (older than two years) are not used to calculate the impact factor for a given journal. (Five-year impact factor analysis, which can be calculated using the Journal Citation Index database, helps smooth out this problem only to some degree.)
  • Different disciplines have different practices regarding tendency to cite larger numbers of references. Higher overall citation rates will bump upward impact factor measurements.
  • Where it's common for large numbers of authors to collaborate on a single paper, such as in Physics, the tendency of authors to cite themselves (and in this case, more authors) will result in increased citation rates.

Pros and Cons of the Impact Factor


  • A vetted, established metric for measuring journal impact within a discipline.
  • Designed to eliminate bias based on journal size and frequency.
  • Individual articles makes an uneven contribution to overall Impact Factor.
  • Impact Factor does not account for certain things, things like context (postive or negative citaion) and intentionality (self-citation).
  • The metric is proprietary to and bound by the contents of the Thomson Reuters database.
  • Citations, on which the Impact Factor is based, count for less than 1% of an article's overall use.


Numerous critiques have been made regarding the use of impact factors. A 2007 study noted that the most fundamental flaw is that impact factors present the mean of data that are not normally distributed, and suggested that it would be more appropriate to present the median of these data. There is also a more general debate on the validity of the impact factor as a measure of journal importance and the effect of policies that editors may adopt to boost their impact factor (perhaps to the detriment of readers and writers). Other criticism focuses on the effect of the impact factor on behavior of scholars, editors and other stakeholders. Others have made more general criticisms, arguing that emphasis on impact factor results from negative influence of neoliberal policies on academia claiming that what is needed is not just replacement of the impact factor with more sophisticated metrics for science publications but also discussion on the social value of research assessment and the growing precariousness of scientific careers in higher education.
Experts stress that there are limitations in using impact factors to evaluate a scholar's work. There are many reasons cited for not relying on impact factor alone to evaluate the output of a particular individual. Among these are the following:

  • A single factor is not sufficient for evaluating an author's work.
  • Journal values are meaningless unless compared within the same discipline. Impact factors vary among disciplines.
  • The impact factor was originally devised to show the impact of a specific journal, not a specific scholar. The quality and impact of the author's work may extend beyond the impact of a particular journal.
According to Jim Testa, a researcher for ThomsonReuters Scientific, the most widespread misuse of the Impact Factor is to evaluate the work of an individual author (instead of a journal). "To say that because a researcher is publishing in a certain journal, he or she is more influential or deserves more credit is not necessarily true. There are many other variables to consider." (interview 6/26/2008 in Thomson Reuters blog entry)

Journal of Addiction Medicine
Journal Profile


The mission of Journal of Addiction Medicine, the official peer-reviewed journal of the American Society of Addiction Medicine, is to promote excellence in the practice of addiction medicine and in clinical research as well as to support Addiction Medicine as a mainstream medical sub-specialty.Under the guidance of an esteemed Editorial Board, peer-reviewed articles published in the Journal focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics including:•addiction and substance use in pregnancy•adolescent addiction and at-risk use•the drug-exposed neonate•pharmacology•all psychoactive substances relevant to addiction, including alcohol, nicotine, caffeine, marijuana, opioids, stimulants and other prescription and illicit substances•diagnosis•neuroimaging techniques•treatment of special populations•treatment, early intervention and prevention of alcohol and drug use disorders•methodological issues in addiction research•pain and addiction, prescription drug use disorder•co-occurring addiction, medical and psychiatric disorders•pathological gambling disorder, sexual and other behavioral addictions•pathophysiology of addiction•behavioral and pharmacological treatments•issues in graduate medical education•recovery•health services delivery•ethical, legal and liability issues in addiction medicine practice•drug testing•self- and mutual-help. None

Highly Cited Keywords


The ISSN of Journal of Addiction Medicine is 1932-0620 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

ISSN (Online)
ISSN (Online)

The ISSN (Online) of Journal of Addiction Medicine is 1935-3227 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

Lippincott Williams and Wilkins Ltd.

Journal of Addiction Medicine is published by Lippincott Williams and Wilkins Ltd. .

Publication Frequency
Publication Frequency

Journal of Addiction Medicine publishes reports - .

2007 - Present

The Publication History of Journal of Addiction Medicine covers 2007 - Present .

Open Access
Open Access

Journal of Addiction Medicine is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

Publication Fee
Publication Fee

There is no publication fee for submiting manuscript to Journal of Addiction Medicine. Journal of Addiction Medicine is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.


The language of Journal of Addiction Medicine is - .

United States

The publisher of Journal of Addiction Medicine is Lippincott Williams and Wilkins Ltd. , which locates in United States .

Selected Articles

Full Title Authors
Full Title Authors
Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions Marion A. Coe · Michelle R. Lofwall · Sharon L. Walsh · Sharon L. Walsh
Predictors of Leaving an Inpatient Medical Withdrawal Service Against Medical Advice: A Retrospective Analysis Hannah K. Knudsen · Michelle R. Lofwall · Sharon L. Walsh · Jennifer R. Havens · Jamie L. Studts · Jamie L. Studts
Does Medical Cannabis Use Increase or Decrease the Use of Opioid Analgesics and Other Prescription Drugs Larry F. Chu · John Sun · Anna Clemenson · Matthew J. Erlendson · Tom Rico · Erika Cornell · Hannah Obasi · Zahra N. Sayyid · Ellen M. Encisco · Jeff Yu · Jamison G. Gamble · J. David Clark · J. David Clark
Reply to Dr Peltz Alicia M. Allen · Samantha Carlson · Tyler A. Bosch · Lynn E. Eberly · Kola Okuyemi · Uma S. Nair · Judith S. Gordon · Judith S. Gordon
High-intensity Interval Training and Continuous Aerobic Exercise Interventions to Promote Self-initiated Quit Attempts in Young Adults Who Smoke: Feasibility, Acceptability, and Lessons Learned From a Randomized Pilot Trial Jenna R. Cummings · A. Janet Tomiyama · Lara A. Ray · Lara A. Ray
Does the Neuroimmune Modulator Ibudilast Alter Food Craving? Results in a Sample With Alcohol Use Disorder Gary Peltz · Gary Peltz
A Flawed Design Produces Flawed Results Daniel J. Paulus · Kirsten J. Langdon · David W. Wetter · Michael J. Zvolensky · Michael J. Zvolensky
Predicting Young Adults Binge Drinking in Nightlife Scenes: An Evaluation of the D-ARIANNA Risk Estimation Model Yukiko Washio · Katrina Mark · Mishka Terplan · Mishka Terplan
Characteristics of Pregnant Women Reporting Cannabis Use Disorder at Substance Use Treatment Entry Madeline C. Frost · Emily C. Williams · Susan Kingston · Caleb J. Banta-Green · Caleb J. Banta-Green
Interest in Getting Help to Reduce or Stop Substance Use Among Syringe Exchange Clients Who Use Opioids Amber D. Seelig · Kara M. Bensley · Emily C. Williams · Richard F. Armenta · Anna C. Rivera · Arthur V. Peterson · Isabel G. Jacobson · Alyson J. Littman · Charles Maynard · Jonathan B. Bricker · Rudolph P. Rull · Edward J. Boyko · Edward J. Boyko
Longitudinal Examination of the Influence of Individual Posttraumatic Stress Disorder Symptoms and Clusters of Symptoms on the Initiation of Cigarette Smoking Kara M. Bensley · Amber D. Seelig · Richard F. Armenta · Anna C. Rivera · Arthur V. Peterson · Isabel G. Jacobson · Alyson J. Littman · Charles Maynard · Jonathan B. Bricker · Edward J. Boyko · Rudolph P. Rull · Emily C. Williams · Emily C. Williams
Posttraumatic Stress Disorder Symptom Association With Subsequent Risky and Problem Drinking Initiation Jacqueline Wong · Barry Saver · James Scanlan · Louis Paul Gianutsos · Yachana Bhakta · Jim Walsh · Abigail Plawman · David Sapienza · Vania Rudolf · Vania Rudolf
Does Maternal Buprenorphine Dose Affect Severity or Incidence of Neonatal Abstinence Syndrome Pierre-François Dancoine · Elodie Gentina · Elodie Gentina
Different Effects of Social Support on Adolescent Smoking and the Mediation by Smartphone Dependence Jarratt D. Pytell · Darius A. Rastegar · Darius A. Rastegar
Who Leaves Early? Factors Associated With Against Medical Advice Discharge During Alcohol Withdrawal Treatment Duc Anh Ngo · Nassima Ait-Daoud · Saumitra V. Rege · Christopher Ding · Lauren Gallion · Christopher P. Holstege · Christopher P. Holstege
Validity of Diagnostic Coding of Alcohol Intoxication Associated With Student University Hospital Emergency Department Visits Parabhdeep Lail · Nadia Fairbairn · Nadia Fairbairn
Patients With Substance Use Disorders Leaving Against Medical Advice: Strategies for Improvement Megan Buresh · Megan Buresh
Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance Cora von Hammerstein · Ruben Miranda · Henri-Jean Aubin · Lucia Romo · Yasser Khazaal · Amine Benyamina · Amandine Luquiens · Amandine Luquiens
Mindfulness and Cognitive Training in a CBT-resistant Patient With Gambling Disorder: A Combined Therapy to Enhance Self-control Sean Cowlishaw · Jim McCambridge · David Kessler · David Kessler
Measuring the Burden of Opioid-related Mortality in Ontario, Canada Marcus A. Bachhuber · Julia H. Arnsten · Chinazo O. Cunningham · Nancy Sohler · Nancy Sohler
Commentary onGaps in the Substance Use Disorder Treatment Referral Process: Provider Perceptions Tara Gomes · Simon Greaves · Mina Tadrous · Muhammad Mamdani · J. Michael Paterson · David N. Juurlink · David N. Juurlink
Medical Marijuana Users are More Likely to Use Prescription Drugs Medically and Nonmedically David Rosenbloom · David Rosenbloom
Combined NMDA Inhibitor Use in a Patient With Multisubstance-induced Psychotic Disorder Kelly E. Moore · Lindsay Oberleitner · Kathryn Z. Smith · Kathleen Maurer · Sherry A. McKee · Sherry A. McKee
Patient and System Characteristics Associated with Performance on the HEDIS Measures of Alcohol and Other Drug Treatment Initiation and Engagement Nicholas Lintzeris · Lauren A. Monds · Consuelo Rivas · Stefanie Leung · Adrian Dunlop · David Newcombe · Carina Walters · Susanna Galea · Nancy White · Mark Montebello · Apo Demirkol · Nicola Swanson · Robert Ali · Robert Ali
Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines Andrea Acevedo · Andrea Acevedo
Improving Quality of Care for SUDS: Where Do We Go From Here? Dimitrios-Rafail Kalaitzopoulos · Konstantinos Chatzistergiou · Anna-Lea Amylidi · Damianos G. Kokkinidis · Dimitrios G. Goulis · Dimitrios G. Goulis
Effect of Methamphetamine Hydrochloride on Pregnancy Outcome: A Systematic Review and Meta-analysis Kirsten J. Langdon · Jafar Bakhshaie · Alicia Lopez · Niloofar Tavakoli · Lorra Garey · Amanda M. Raines · Brooke Y. Kauffman · Norman B. Schmidt · Michael J. Zvolensky · Michael J. Zvolensky
The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program (M-Paws): A Randomized, Double-Blind, Placebo Controlled Trial Meghan Gannon · Michael J. Mackenzie · Karol Kaltenbach · Diane J. Abatemarco · Diane J. Abatemarco
Anxiety Sensitivity Physical and Cognitive Concerns in Relation to Smoking-oriented Cognition: An Examination Among Treatment-seeking Adults Who Smoke Walter Roberts · Julia M. Shi · Jeanette M. Tetrault · Sherry A. McKee · Sherry A. McKee
Effects of Varenicline Alone and in Combination With Low-dose Naltrexone on Alcohol-primed Smoking in Heavy-drinking Tobacco Users: A Preliminary Laboratory Study Matteo Caloro · Giuseppa Calabrò · Eleonora De Pisa · Enrico Rosini · Georgios D. Kotzalidis · Davide Lonati · Carlo Locatelli · Pietro Papa · Fabrizio Schifano · Paolo Girardi · Paolo Girardi
Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal Marek Mędraś · Anna Brona · Paweł Jóźków · Paweł Jóźków
Gaps in the Substance Use Disorder Treatment Referral Process: Provider Perceptions Theodore L. Caputi · Keith Humphreys · Keith Humphreys
The Central Effects of Androgenic-anabolic Steroid Use Napoleon Waszkiewicz · Witold Olański · Sylwia Chojnowska · Urszula Kołakowska · Katarzyna Plewa · Włodzimierz Mielech · Anna Bagniuk-Plewa · Anna Wasilewska · Agata Szulc · Sławomir Dariusz Szajda · Krzysztof Zwierz · Krzysztof Zwierz
Serum Exoglycosidases in Children and Adolescents With Harmful Alcohol Use Victoria H. Coleman-Cowger · Katrina Mark · Zachary R. Rosenberry · Bartosz Koszowski · Mishka Terplan · Mishka Terplan
A Pilot Randomized Controlled Trial of a Phone-based Intervention for Smoking Cessation and Relapse Prevention in the Postpartum Period Cindy Parks Thomas · Grant Ritter · Alex H. S. Harris · Deborah W. Garnick · Kenneth I Freedman · Barbara Herbert · Barbara Herbert
Applying American Society of Addiction Medicine Performance Measures in Commercial Health Insurance and Services Data Maria Wamsley · Jason M. Satterfield · Alexa Curtis · Lena Lundgren · Derek D. Satre · Derek D. Satre
Alcohol and Drug Screening, Brief Intervention, and Referral to Treatment (SBIRT) Training and Implementation: Perspectives from 4 Health Professions Jean-Baptiste Trabut · Camille Barrault · Hélène Charlot · Damien Carmona · Anne Bourdel · Mustapha Benslimane · Murielle François · Willy Kini-Matondo · Richard Causse · Françoise Roudot-Thoraval · Christophe Hézode · Christophe Hézode
Integrated Care for the Use of Direct-acting Antivirals in Patients With Chronic Hepatitis C and Substance Use Disorder Claire E. Wilcox · J. Scott Tonigan · Michael P. Bogenschutz · Joshua Clifford · Rose Bigelow · Tracy Simpson · Tracy Simpson
A Randomized, Placebo-controlled, Clinical Trial of Prazosin for the Treatment of Alcohol Use Disorder Claire E. Blevins · Nishi Rawat · Michael D. Stein · Michael D. Stein
Identification of Gambling Problems in Primary Care: Properties of the NODS-CLiP Screening Tool Anupriya Gogne · Shannon Erisman · Shannon Erisman
Stimulant-induced Psychosis in the Postpartum Period: A Case Report Sara Ling · Kristin Cleverley · Sarah Brennenstuhl · Kirstin Bindseil · Kirstin Bindseil
Billing Practices Among US Tobacco Use Treatment Providers Ajay Manhapra · Anirban Chakraborty · Albert J. Arias · Albert J. Arias
Is the National Institutes on Alcohol and Alcoholism Screening Guide Useful for Identifying Adolescents at Risk for Later Cigarette Smoking? A Prospective Study in Primary Care Clinics Fred Leland McClure · Justin K. Niles · Harvey W. Kaufman · Jeffrey Gudin · Jeffrey Gudin
Menstrual Cycle in Women Who Co-use Marijuana and Tobacco Elon E. Richman · Nathan J. Skoller · Bernice Fokum · Brandi A. Burke · Chelsea A. Hickerson · Robert O. Cotes · Robert O. Cotes
α-Pyrrolidinopentiophenone (Flakka) Catalyzing Catatonia: A Case Report and Literature Review Ted Stoklosa · Paul S. Haber · Paul S. Haber
Regarding Methadone and the QTc Interval: Paucity of Clinically Significant Factors in a Retrospective Cohort, Gavin Bart et al Gavin Bart · Bradley A. Bart · Bradley A. Bart
Author Response to Stoklosa and Haber Igam Bagra · Vijay Krishnan · Ravindra Rao · Alok Agrawal · Alok Agrawal
Does Cannabis Use Influence Opioid Outcomes and Quality of Life Among Buprenorphine Maintained Patients? A Cross-sectional, Comparative Study Nur Afiqah Mohd Salleh · Lindsey Richardson · Thomas Kerr · Jean Shoveller · Julio Montaner · Adeeba Kamarulzaman · M-J Milloy · M-J Milloy
A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs John J. McCarthy · Ernest J. Vasti · Martin H. Leamon · Joseph Graas · Coburn Ward · Catherine Fassbender · Catherine Fassbender
Evaluating the Validity of the DSM-5 Alcohol Use Disorder Diagnostic Criteria in a Sample of Treatment-seeking Native Americans David A. Gilder · David A. Gilder
Drug Misuse and Hepatitis C Virus Infection Profiles for Three Generations of Patients Being Monitored for Prescription Drug Adherence Kelsey N. Serier · Kamilla L. Venner · Ruth E. Sarafin · Ruth E. Sarafin
The Use of Serum Methadone/Metabolite Ratios to Monitor Changing Perinatal Pharmacokinetics Lisbet S. Lundsberg · Stephanie Peglow · Neena Qasba · Kimberly A. Yonkers · Aileen M. Gariepy · Aileen M. Gariepy
Is Preconception Substance Use Associated With Unplanned or Poorly Timed Pregnancy Azin Khazaeli · Jason M. Jerry · Mohsen Vazirian · Mohsen Vazirian
Treatment of Addiction to Kratom With Buprenorphine-naloxone Michael Frost · Raymond Bobb · Raymond Bobb
Buprenorphine Implant Removal 7 Years Postinsertion: A Case Report Erika Litvin Bloom · Michael V. Burke · Chris Kotsen · Adam O. Goldstein · Carol Ripley-Moffitt · Michael B. Steinberg · Mary Dailey · Laura E. Hunt · Matthew P. Bars · Matthew P. Bars
Topiramate Pharmacotherapy for Alcohol Use Disorder and Other Addictions: A Narrative Review Jennifer J. Carroll · Josiah D. Rich · Traci C. Green · Traci C. Green
Outcome Differences in Neonates Exposed In-Utero to Opioids Managed in the NICU Versus Pediatric Floor William G. Shadel · Rachana Seelam · Layla Parast · Lisa S. Meredith · Elizabeth J. D’Amico · Elizabeth J. D’Amico
The More Things Change: Buprenorphine/naloxone Diversion Continues While Treatment Remains Inaccessible Bhavita Kumari · Syeda Kanwal Aslam · Sidra Zaheer · Syed Omair Adil · Kashif Shafique · Kashif Shafique
Systemic Inflammatory Markers Among Waterpipe Smokers, Cigarette Smokers, and Nonsmokers Jon E. Grant · Sarah A. Redden · Katherine Lust · Samuel R. Chamberlain · Samuel R. Chamberlain
Nonmedical Use of Stimulants Is Associated With Riskier Sexual Practices and Other Forms of Impulsivity Lorra Garey · Brooke Y. Kauffman · Kara Manning · Samar A. Taha · Norman B. Schmidt · Clayton Neighbors · Michael J. Zvolensky · Michael J. Zvolensky
The Effect of Positive and Negative Affect on Early Treatment Milestones in the Context of Integrated Smoking Treatment Hannah K. Knudsen · Randy Brown · Nora Jacobson · Julie Horst · Jee Seon Kim · Elizabeth Collier · Sanford Starr · Lynn Madden · Eric Haram · Todd Molfenter · Todd Molfenter
Pharmacotherapy, Resource Needs, and Physician Recruitment Practices in Substance Use Disorder Treatment Programs Hussam Jefee-Bahloul · Lantie Jorandby · Albert J. Arias · Albert J. Arias
Topiramate Treatment of Alcohol Use Disorder in Clinical Practice Ayodeji Okusanya · Xiaofan Li · Xiaofan Li
Loperamide Abuse and Dependence: Clinical Features and Treatment Considerations Sharon S. Allen · Sharon S. Allen
A Flawed Design Produces Flawed Results Shannon Gwin Mitchell · Jan Gryczynski · Robert P. Schwartz · Robert P. Schwartz
Commentary onThe More Things Change: Buprenorphine/Naloxone Diversion Continues While Treatment is Inaccessible Robert S. Howe · Robert S. Howe
A Flawed Design Produces Flawed Results Anne C. Fernandez · Christopher Bush · Erin E. Bonar · Frederic C. Blow · Maureen A. Walton · Amy S.B. Bohnert · Amy S.B. Bohnert
Alcohol and Drug Overdose and the Influence of Pain Conditions in an Addiction Treatment Sample Steven L. Proctor · Autumn Birch · Philip L. Herschman · Philip L. Herschman
Medication Treatment With Methadone or Buprenorphine: Differential Reasons for Premature Discharge Crystal Jicha · David Saxon · Michelle R. Lofwall · Laura Fanucchi · Laura Fanucchi
Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review Sara Lammert · Katherine Harrison · Nicole Tosun · Sharon S. Allen · Sharon S. Allen
The Impact of Early Substance Use Disorder Treatment Response on Treatment Outcomes Among Pregnant Women With Primary Opioid Use Jacob Borodovsky · Sharon Levy · Marc Fishman · Lisa A. Marsch · Lisa A. Marsch
Commentary onEvaluating the Validity of DSM-5 Alcohol Use Disorder Diagnostic Criteria in a Sample of Treatment Seeking Native Americans Joanna G. Katzman · Nina Greenberg · Mikiko Y. Takeda · Monica Moya Balasch · Monica Moya Balasch
Characteristics of Patients With Opioid Use Disorder Associated With Performing Overdose Reversals in the Community: An Opioid Treatment Program Analysis Hendrée E. Jones · Karol Kaltenbach · Tara Benjamin · Elisha M. Wachman · Kevin E. O’Grady · Kevin E. O’Grady
Does Performing Preplacement Workplace Hair Drug Testing Influence US Department of Transportation Random and Postaccident Urine Drug Test Positivity Rates Michael A. Grasso · Clare T. Grasso · David A. Jerrard · David A. Jerrard
Substance Use Disorder Assessment, Diagnosis, and Management for Patients Hospitalized With Severe Infections Due to Injection Drug Use Amy L. Lembeck · Deborah Tuttle · Robert Locke · Laura Lawler · Pamela Jimenez · Amy Mackley · David A. Paul · David A. Paul
Opioid Use Disorders Attributed to Tramadol Among Egyptian University Students Emily C. Williams · Chris L. Bryson · Haili Sun · David H. Au · Katharine A. Bradley · Katharine A. Bradley
Association Between Alcohol Use and Angina Symptoms Among Outpatients From the Veterans Health Administration James W. Price · James W. Price
How Should Remote Clinical Monitoring Be Used to Treat Alcohol Use Disorders?: Initial Findings From an Expert Round Table Discussion Louis von Theobald · Morgane Rousselet · Jennyfer Cholet · Hélène Debar · David Boels · Caroline Victorri-Vigneau · Marie Grall-Bronnec · Marie Grall-Bronnec
Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-year Retrospective Data Analysis Hendrée E. Jones · Mishka Terplan · Marjorie Meyer · Marjorie Meyer
Medically assisted withdrawal (Detoxification): Considering the mother-infant dyad Jan Klimas · Elaine Fernandes · Kora DeBeck · Kanna Hayashi · M.-J. Milloy · Thomas Kerr · Walter Cullen · Evan Wood · Evan Wood
Preliminary Results and Publication Impact of a Dedicated Addiction Clinician Scientist Research Fellowship Katrina Mark · Jan Gryczynski · Ellen Axenfeld · Robert P. Schwartz · Mishka Terplan · Mishka Terplan
Pregnant Womenʼs Current and Intended Cannabis Use in Relation to Their Views Toward Legalization and Knowledge of Potential Harm Joe Hong · Jooyeon Lee · Holly Totouom-Tangho · Norma Ramos Dunn · Ronnie Gorman Swift · Ronnie Gorman Swift
Methadone-Induced Hyperhidrosis Treated With Oxybutynin Travis D. Olives · Rebecca L. Kornas · Russell Fujisawa · Jon B. Cole · Jon B. Cole
Unexpected Complication of Cocaine-associated Anti-neutrophil Cytoplasmic Antibody Vasculitis Related to Persistent In-hospital Cocaine Use Amy B. Jessop · Jeffrey K. Hom · Monika Burke · Monika Burke
Variation in the Viral Hepatitis and HIV Policies and Practices of Methadone Maintenance Programs Annemiek Buizert · Ruby Sharma · Hille Koppen · Hille Koppen
When the Laughing Stops: Subacute Combined Spinal Cord Degeneration Caused by Laughing Gas Use Eric M. Schmidt · Shalini Gupta · Thomas Bowe · Laura S. Ellerbe · Tyler E. Phelps · John W. Finney · Keith Humphreys · Jodie A. Trafton · Megan E. Vanneman · Alex H. S. Harris · Alex H. S. Harris
Predictive Validity of Outpatient Follow-up After Detoxification as a Quality Measure Alan Gordon · Adi Jaffe · A. Thomas McLellan · Gary Richardson · Gregory Skipper · Michel Sucher · Carlos F. Tirado · Harold C. Urschel · Harold C. Urschel
Inpatient Gamma-Hydroxybutyrate Detoxification: A Case Report Describing Day-to-day Therapeutic Management Itai Danovitch · Alexander J. Steiner · Anna Kazdan · Matthew Goldenberg · Margaret Haglund · James Mirocha · Katherine L. Collison · Brigitte Vanle · Jonathan Dang · Waguih William IsHak · Waguih William IsHak
Patients Knowledge and Attitudes Towards Regular Alcohol Urine Screening: A Survey Study Bobbi Jo H. Yarborough · Felicia W. Chi · Carla A. Green · Agatha Hinman · Jennifer R. Mertens · Arne Beck · Michael Horberg · Constance Weisner · Cynthia I. Campbell · Cynthia I. Campbell
Analysis of Patient-reported Outcomes of Quality of Life and Functioning Before and After Treatment of Major Depressive Disorder Comorbid With Alcohol Use Disorders Tae Woo Park · Tae Woo Park
Should Patients With Substance Use Disorders Be Prescribed Benzodiazepines?No Richard Saitz · Richard Saitz
Should Benzodiazepines Be Used to Treat Anxiety in People With Substance Use Disorders? Contentious Debate With Similar Conclusions Pooja Lagisetty · Donovan T. Maust · Michele Heisler · Amy S.B. Bohnert · Amy S.B. Bohnert
Physical and mental health comorbidities associated with primary care visits for substance use disorders Kent Hoffman · Marvin L. Peyton · Michael Sumner · Michael Sumner
Safety of a Rapidly Dissolving Buprenorphine/Naloxone Sublingual Tablet (BNX-RDT) for Treatment of Opioid Dependence: A Multicenter, Open-label Extension Study Paul H. Earley · Jacqueline Zummo · Asli Memisoglu · Bernard L. Silverman · David R. Gastfriend · David R. Gastfriend
Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid Dependence Ajay Manhapra · Robert A. Rosenheck · Robert A. Rosenheck
Tobacco Use Disorder Among Patients With Smoking-related Chronic Medical Disease: Association With Comorbid Substance Use Disorders Della Berhanu · Marie Diener-West · Andrea Ruff · Wendy W. Davis · David D. Celentano · Vivian F. Go · Vivian F. Go
Associations Between Khat Use and HIV Risk and Status Among Voluntary Counseling and Testing Center Clients in Addis Ababa, Ethiopia Jake M. Najman · Fairlie McIlwraith · Robert Kemp · Andrew Smirnov · Andrew Smirnov
When knowledge and experience do not help: a study of nonfatal drug overdoses Pablo Barrio · Lídia Teixidor · Lluisa Ortega · Mercè Balcells · Eduard Vieta · Antoni Gual · Antoni Gual
Debate: Are Benzodiazepines Appropriate Treatments for Patients with Substance Use Disorders? Yes Robert L. DuPont · Robert L. DuPont
Perceptions of Neighborhood Mediate the Relationship Between PTSD Symptoms and Coping in a Neighborhood-Matched Substance-Using Sample Gavin Bart · Zachary Wyman · Qi Wang · James S. Hodges · Rehan Karim · Bradley A. Bart · Bradley A. Bart
Examining the Association Between Psychiatric Disorders and Cocaine Binges: Results From the COSMO Study Sara K. Hertzel · Jennifer R. Schroeder · Landhing M. Moran · Anika A. H. Alvanzo · William J. Kowalczyk · David H. Epstein · Kenzie L. Preston · Karran A. Phillips · Karran A. Phillips
Dispositional Mindful Attention in Relation to Negative Affect, Tobacco Withdrawal, and Expired Carbon Monoxide On and After Quit Day Derek C. Chang · Jan Klimas · Evan Wood · Nadia Fairbairn · Nadia Fairbairn
The Nicotine Content of a Sample of E-cigarette Liquid Manufactured in the United States Louis-Christophe Juteau · Élise Roy · Djamal Berbiche · Nelson Arruda · Julie Bruneau · Didier Jutras-Aswad · Didier Jutras-Aswad
An Innovative Model for Naloxone Use Within an OTP Setting: A Prospective Cohort Study Barrett H. Raymond · Katreena Collette-Merrill · Roger G. Harrison · Sabrina Jarvis · Ryan Jay Rasmussen · Ryan Jay Rasmussen
Neurocognitive Profiling of Adult Treatment Seekers Enrolled in a Clinical Trial of a Web-delivered Intervention for Substance Use Disorders Joanna G. Katzman · Mikiko Y. Takeda · Snehal R. Bhatt · Monica Moya Balasch · Nina Greenberg · Howard Yonas · Howard Yonas
The Interaction of Depressive Symptoms and Hazardous Drinking in Relation to Tobacco Craving Among Treatment Seeking Depressed Smokers: Sex Differences Efrat Aharonovich · Aimee Campbell · Matisyahu Shulman · Mei-Chen Hu · Tiffany Kyle · Theresa Winhusen · Edward V. Nunes · Edward V. Nunes
Using Choice Architecture to Integrate Substance Use Services with Primary Care: Commentary on Donohue et al. (2017) Rubén Rodríguez-Cano · Ana López-Durán · Daniel J. Paulus · Carmela Martínez-Vispo · Elena Fernández del Río · Elisardo Becoña · Michael J. Zvolensky · Michael J. Zvolensky
Acceptability of an Opioid Relapse Prevention Text-message Intervention for Emergency Department Patients Leo Beletsky · Leo Beletsky
Use of Smoking Cessation Methods Among Patients Receiving Office-based Buprenorphine Maintenance Treatment Brian Suffoletto · Joseph Yanta · Ryan Kurtz · Gerald Cochran · Antoine Douaihy · Tammy Chung · Tammy Chung
Payer policy behavior towards opioid pharmacotherapy treatment in Ohio Pooja A. Shah · Chinazo O. Cunningham · Mia T. Brisbane · Joseph Deluca · Shadi Nahvi · Shadi Nahvi
Patients Experiences of Using a Cellular Photo Digital Breathalyzer for Treatment Purposes Todd Molfenter · Carol Sherbeck · Sandy Starr · Jee Seon Kim · Mark Zehner · Andrew Quanbeck · Nora Jacobson · Dennis McCarty · Dennis McCarty
Effects of Global Payment and Accountable Care on Medication Treatment for Alcohol and Opioid Use Disorders Christina Nehlin · Kristina Carlsson · Caisa Öster · Caisa Öster
Optimizing Pregnancy Treatment Interventions for Moms (OPTI-Mom): A Pilot Study Julie M. Donohue · Colleen L. Barry · Elizabeth A. Stuart · Shelly F. Greenfield · Zirui Song · Michael E. Chernew · Haiden A. Huskamp · Haiden A. Huskamp
Pattern of Methamphetamine Use and the Time Lag to Methamphetamine Dependence Gerald Cochran · Valerie Hruschak · Walitta Abdullah · Elizabeth E. Krans · Antoine Douaihy · Stephanie Bobby · Rachel Fusco · Ralph E. Tarter · Ralph E. Tarter
Opioid Addiction in Pregnancy: Does Depression Negatively Impact Adherence With Prenatal Care? Pongkwan Yimsaard · Michael M. Maes · Viroj Verachai · Rasmon Kalayasiri · Rasmon Kalayasiri
Relationships Between Components of Emotional Intelligence and Suicidal Behavior in Alcohol-dependent Patients Lauren Hensley · Suela Sulo · Sarah Kozmic · Barbara V. Parilla · Barbara V. Parilla
The Economic Burden of Pathological Gambling and Co-occurring Mental Health and Substance Use Disorders Maciej Kopera · Andrzej Jakubczyk · Anna Klimkiewicz · Hubert Suszek · Aleksandra Krasowska · Kirk J. Brower · Marcin Wojnar · Marcin Wojnar · Marcin Wojnar
Predicting Smoking Lapses in the First Week of Quitting: An Ecological Momentary Assessment Study Rosa Rodriguez-Monguio · Evelyn Brand · Rachel A. Volberg · Rachel A. Volberg
Anxiety, Depression, and Pain Symptoms: Associations With the Course of Marijuana Use and Drug Use Consequences Among Urban Primary Care Patients Catherine Bolman · Peter Verboon · Vivianne Thewissen · Viviane Boonen · Karin Soons · Nele Jacobs · Nele Jacobs
Concurrent Use of Opioids and Benzodiazepines: Evaluation of Prescription Drug Monitoring by a United States Laboratory Nicolas Bertholet · Debbie M. Cheng · Tibor P. Palfai · Christine Lloyd-Travaglini · Jeffrey H. Samet · Richard Saitz · Richard Saitz
The Unexpected Urine Test: A Matter Far From Simple Fred Leland McClure · Justin K. Niles · Harvey W. Kaufman · Jeffrey Gudin · Jeffrey Gudin
Physicians Decision-making When Implementing Buprenorphine With New Patients: Conjoint Analyses of Data From a Cohort of Current Prescribers Stefan G. Kertesz · Stefan G. Kertesz
Methadone and the QTc Interval: Paucity of Clinically Significant Factors in a Retrospective Cohort Nikki Bozinoff · Bradley J. Anderson · Genie L. Bailey · Michael D. Stein · Michael D. Stein
Coronary Plaque Progression and Regression in Asymptomatic African American Chronic Cocaine Users With Obstructive Coronary Stenoses: A Preliminary Study Anna Persson · Sudie E. Back · Therese K. Killeen · Kathleen T. Brady · Melanie L. Schwandt · Markus Heilig · Åsa Magnusson · Åsa Magnusson
Correlates of Stigma Severity Among Persons Seeking Opioid Detoxification Medhat M. Bassiony · Mohamed Abdelghani · Ghada M. Salah El-Deen · Mervat S. Hassan · Hayam El-Gohari · Usama M. Youssef · Usama M. Youssef
Prescriptions Written for Opioid Pain Medication in the Veterans Health Administration Between 2000 and 2016 Michelle Tuten · Heather Fitzsimons · Martin Hochheimer · Hendrée E. Jones · Margaret S. Chisolm · Margaret S. Chisolm
A Case of Opioid Overdose and Subsequent Death After Medically Supervised Withdrawal: The Problematic Role of Rapid Tapers for Opioid Use Disorder Cristina Crocamo · Francesco Bartoli · Cristina Montomoli · Giuseppe Carrà · Giuseppe Carrà
Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure ( COPE): A Pilot Study in Alcohol-dependent Women Wanhong Zheng · Michael Nickasch · Laura Lander · Sijin Wen · Minchan Xiao · Patrick Marshalek · Ebony Dix · Carl Sullivan · Carl Sullivan
Alcohol use disorders in Argentinian girls and women 12 months before delivery: comparison of DSM-IV, DSM-5, and ICD-10 diagnostic criteria Veit Sandfort · David A. Bluemke · Jose D. Vargas · Jose D. Vargas · Jeffrey A. Brinker · Gary Gerstenblith · Thomas S. Kickler · Gang Zheng · Ji Li · Shaoguang Chen · Hong Lai · Elliot K. Fishman · Shenghan Lai · Shenghan Lai
Case Report of Physiologic Phenibut Dependence Treated With a Phenobarbital Taper in a Patient Being Treated With Buprenorphine Cornel N. Stanciu · Magdalena Glass · Brian C. Muzyka · Oliver M. Glass · Oliver M. Glass
Multiple Cerebral Infarcts in a Young Patient Associated With Marijuana Use Corry D. Bondi · Corry D. Bondi
Sex Differences in Methamphetamine Use and Dependence in a Thai Treatment Center Jill M. Williams · Marc L. Steinberg · Alexandra N. Kenefake · Michael V. Burke · Michael V. Burke
Misuse of Novel Synthetic Opioids: A Deadly New Trend Kevin Fiscella · Kevin Fiscella
Addiction Research Training Programs: Four Case Studies and Recommendations for Evaluation Matthew P. Prekupec · Peter A. Mansky · Michael H. Baumann · Michael H. Baumann
Methadone Management of Withdrawal Associated With Loperamide-related Opioid Use Disorder Aimee Campbell · Sudie E. Back · Jamie S. Ostroff · Denise A. Hien · Marc N. Gourevitch · Christine E. Sheffer · Kathleen T. Brady · Kathleen Hanley · Sewit Bereket · Sarah Book · Sarah Book
Urine Drug Testing in a Family Medicine Residency Practice S. D. Singh · Ankit Gupta · Siddharth Sarkar · Siddharth Sarkar
Response to Urine Drug Testing in a Family Residency Practice Hunter E. Woodall · Natawadee Young · Amanda Davis · Mary Beth Wright · Mary Beth Wright
Accuracy of Diagnosis and International Classification of Diseases; Tenth Revision Coding for Alcohol Dependence, Alcohol Withdrawal, and Alcohol-withdrawal Delirium Among Inpatients at a University Hospital Michael G. McDonell · Imara I. West · Richard K. Ries · Dennis M. Donovan · Kristin Bumgardner · Chris Dunn · David C. Atkins · Peter Roy-Byrne · Charles Maynard · Charles Maynard
Appropriate Use of Drug Testing in Clinical Addiction Medicine Wandee Wansrisuthon · Woraphat Ratta-apha · Lakkhana Thongchot · Pornjira Pariwatcharakul · Pornjira Pariwatcharakul
How to Deliver a More Persuasive Message Regarding Addiction as a Medical Disorder Margaret Jarvis · Jessica Williams · Matthew Hurford · Dawn Lindsay · Piper Lincoln · Leila Giles · Peter F. Luongo · Taleen Safarian · Taleen Safarian
Ondansetron Does Not Reduce Withdrawal in Patients With Physical Dependence on Chronic Opioid Therapy Keith Humphreys · Keith Humphreys
Associations Between Physical Pain, Pain Management, and Frequency of Nonmedical Prescription Opioid Use Among Young Adults: A Sex-specific Analysis Larry F. Chu · John Sun · Anna Clemenson · Matthew J. Erlendson · Tom Rico · Erika Cornell · Hannah Obasi · Zahra N. Sayyid · Ellen M. Encisco · Jeff Yu · Jamison G. Gamble · Ian Carroll · J. David Clark · J. David Clark
Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia Tristan I. Evans · Elliott J. Liebling · Traci C. Green · Scott E. Hadland · Melissa A. Clark · Brandon D. L. Marshall · Brandon D. L. Marshall
Meth Mouth: An Interdisciplinary Review of a Dental and Psychiatric Condition Emmanuel Fortier · Maryam Alavi · Julie Bruneau · Michelle Micallef · Jacinta Perram · Sanjeev Sockalingam · Adrian Dunlop · Annie C. Balcomb · Carolyn Day · Carla Treloar · Nicky Bath · Paul S. Haber · Gregory J. Dore · Jason Grebely · Jason Grebely
Treating Smoking in Adults With Co-occurring Acute Psychiatric and Addictive Disorders Emily Brunner · Robert Levy · Robert Levy
High Mortality Among Patients With Opioid Use Disorder in a Large Healthcare System Smita Das · Norval J. Hickman · Judith J. Prochaska · Judith J. Prochaska
Beyond the Treatment Box: Perspectives on the Federal Response to Opioid Use, Pregnancy, and Neonatal Abstinence Syndrome Yih-Ing Hser · Larissa Mooney · Andrew J. Saxon · Karen Miotto · Douglas S. Bell · Yuhui Zhu · Di Liang · David Huang · David Huang
Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance Mishka Terplan · Mishka Terplan
Extended-release Injectable Naltrexone (xr-ntx) With Intensive Psychosocial Therapy for Amphetamine-dependent Persons Seeking Treatment: A Placebo-controlled Trial Stacey L. Klaman · Krystyna Isaacs · Anne Leopold · Joseph Perpich · Susan Hayashi · Jeff Vender · Melinda Campopiano · Hendrée E. Jones · Hendrée E. Jones
Vermont Hub-and-spoke Model of Care for Opioid Use Disorder: Development, Implementation, and Impact Valgerdur Runarsdottir · Ingunn Hansdottir · Thorarinn Tyrfingsson · Magnus Einarsson · Karen L. Dugosh · Charlotte Royer-Malvestuto · Helen M. Pettinati · Jag Khalsa · George E. Woody · George E. Woody
Institutional Substance Use Disorder Intervention Improves General Internist Preparedness, Attitudes, and Clinical Practice John R. Brooklyn · Stacey C. Sigmon · Stacey C. Sigmon
Erectile Dysfunction Among Patients on Methadone Maintenance Therapy and Its Association With Quality of Life Curtis Bone · Lilian Gelberg · Mani Vahidi · Barbara Leake · Julia Yacenda-Murphy · Ronald Andersen · Ronald Andersen
Pain Interference, Psychopathology, and General Medical Conditions Among Black and White Adults in the US General Population Mariana Beatriz López · Karina Conde · Mariana Cremonte · Mariana Cremonte
Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System Tae Woo Park · Lewei Allison Lin · Avinash Hosanagar · Amanda Kogowski · Katie Paige · Amy S.B. Bohnert · Amy S.B. Bohnert
Sex Differences in Cannabis Use Disorder Diagnosis Involved Hospitalizations in the United States Leila Costa Volpon · Camila Lacerda Muniz de Melo Sousa · Silvia Keiko Kavaguti Moreira · Sara Reis Teixeira · Ana Paula de Carvalho Panzeri Carlotti · Ana Paula de Carvalho Panzeri Carlotti
Mephentermine Dependence in a Young Athlete: Case Report With Review of Literature Raphael J. Leo · Muhammad A. Ghazi · Kelly S. Jaziri · Kelly S. Jaziri
Impact of Mindfulness-based Parenting on Women in Treatment for Opioid Use Disorder Jales Clemente · Sandra Cristina Pillon · Jair de Jesus Mari · Cláudio Jerônimo da Silva · Paulo Roberto Oliveira Henrique Santana · Alessandra Diehl · Alessandra Diehl
Nitrite Inhalant Use and HIV Infection Among Chinese Men Who Have Sex With Men in 2 Large Cities in China Sarah M. Bagley · Scott E. Hadland · Brittany L. Carney · Richard Saitz · Richard Saitz
Family Medicine Physicians With Substance Use Disorder: A 5-year Outcome Study Declan T. Barry · Corey Pilver Glenn · Rani A. Hoff · Marc N. Potenza · Marc N. Potenza
Intentional Intra-arterial Injection of Heroin: A Case Report John S. Rose · Michael D. Campbell · Peter Yellowlees · Gregory E. Skipper · Robert L. DuPont · Robert L. DuPont
Dystonia in Methylphenidate Withdrawal: A Case Report Joji Suzuki · Erin S. Valenti · Erin S. Valenti
Cannabis as Secondary Drug Is Not Associated With a Greater Risk of Death in Patients With Opiate, Cocaine, or Alcohol Dependence Lara Grau-López · Constanza Daigre · Nestor Mercado · M. Casas · Carlos Roncero · Carlos Roncero
COMT and BDNF Gene Variants Help to Predict Alcohol Consumption in Alcohol-dependent Patients Daniel Fuster · Arantza Sanvisens · Ferran Bolao · Paola Zuluaga · Inmaculada Rivas · Magí Farré · Jordi Tor · Robert Muga · Robert Muga
Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone Anna Klimkiewicz · Anna Mach · Andrzej Jakubczyk · Jakub Klimkiewicz · Anna Wnorowska · Maciej Kopera · Sylwia Fudalej · Margit Burmeister · Kirk J. Brower · Marcin Wojnar · Marcin Wojnar · Marcin Wojnar
Paraphilic Thoughts, Behaviors and Sex Addiction in a Sample of Persons Who Use Drugs: A Cross-Sectional Study Swapnil Gupta · Ryan Wallace · Jordan Sloshower · Jordan Sloshower
A Review of Alprazolam Use, Misuse, and Withdrawal Sarah E. Wakeman · Sarah E. Wakeman
To Improve Substance Use Disorder Prevention, Treatment and Recovery: Engage the Family Nassima Ait-Daoud · Allan Scott Hamby · Sana Sharma · Derek Blevins · Derek Blevins
Risk Factors Associated With Skin and Soft Tissue Infections Among Hospitalized People Who Inject Drugs Alicia S. Ventura · Sarah M. Bagley · Sarah M. Bagley
Synthetic Cannabis Analogues and Suicidal Behavior: Case Report Kristina T. Phillips · Bradley J. Anderson · Debra S. Herman · Jane M. Liebschutz · Michael D. Stein · Michael D. Stein
Addressing Stigma in Medication Treatment of Adolescents With Opioid Use Disorder Pedro Oliveira · Ana Sofia Félix Morais · N. Madeira · N. Madeira
Medications For Addiction Treatment: Changing Language to Improve Care Yih-Ing Hser · David Huang · Andrew J. Saxon · George E. Woody · Andrew L. Moskowitz · Abigail G. Matthews · Walter Ling · Walter Ling
Addiction is More Than a Substance Use Disorder Xiaofang Wang · Yanqi Li · Zunyou Wu · Zhenzhu Tang · Kathleen H. Reilly · Quanxing Nong · Quanxing Nong
Comparison of Post-Cesarean Section Opioid Analgesic Requirements in Women With Opioid Use Disorder Treated With Methadone or Buprenorphine William J. Kowalczyk · Jeremiah W. Bertz · Landhing M. Moran · Karran A. Phillips · Udi E. Ghitza · David H. Epstein · Kenzie L. Preston · Kenzie L. Preston
Nonmedical Prescription Opioid Use for the Self-treatment of Pain in Young Adults: A National Shame Raju Hajela · Raju Hajela
Screening Adolescents for Alcohol Use: Tracking Practice Trends of Massachusetts Pediatricians Ryan Graddy · Darius A. Rastegar · Darius A. Rastegar
Impact of a Mandated Change in Buprenorphine Formulation Sean Grant · Benjamin Colaiaco · Aneesa Motala · Roberta Shanman · Marika Booth · Melony E. Sorbero · Susanne Hempel · Susanne Hempel
Mindfulness-based Relapse Prevention for Substance Use Disorders: A Systematic Review and Meta-analysis Annmarie Vilkins · Sarah M. Bagley · Kristen A. Hahn · Florencia Rojas-Miguez · Elisha M. Wachman · Kelley Saia · Daniel P. Alford · Daniel P. Alford
Clonidine Increases the Likelihood That Abstinence Can Withstand Unstructured Time in Buprenorphine-maintained Outpatients Richard Saitz · Richard Saitz
Valid, Reproducible, Clinically Useful, Nonstigmatizing Terminology for the Disease and Its Treatment: Addiction, Substance Use Disorder, and Medication Natacha M. De Genna · Thomas Ylioja · Anna Schulze · Christine Manta · Antoine Douaihy · Esa M. Davis · Esa M. Davis
Electronic Cigarette Use Among Counseled Tobacco Users Hospitalized in 2015 Steven D. Passik · Steven D. Passik
Online Sales of Unscheduled Pharmaceutical Agents: A Case Report of Tianeptine Use in the United States Sharon Levy · Rosemary Ziemnik · Sion Kim Harris · Lily Rabinow · Louise Breen · Christina Fluet · Heather Strother · John Straus · John Straus
Reducing Problematic Benzodiazepine Use Among Individuals Enrolled in Methadone Treatment Programs Jasmine McEachern · Keith Ahamad · Seonaid Nolan · Annabel Mead · Evan Wood · Jan Klimas · Jan Klimas
Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film Patrick R. Krill · Ryan Johnson · Linda Albert · Linda Albert
A needs assessment of the number of comprehensive addiction care physicians required in a Canadian setting Michael G. McDonell · Meredith C. Graves · Imara I. West · Richard K. Ries · Dennis M. Donovan · Kristin Bumgardner · Antoinette Krupski · Chris Dunn · Charles Maynard · David C. Atkins · Peter Roy-Byrne · Peter Roy-Byrne
Utility of Point-of-care Urine Drug Tests in the Treatment of Primary Care Patients With Drug Use Disorders Anita Ram · Michelle Tuten · Margaret S. Chisolm · Margaret S. Chisolm
Substance use disorders among danish physicians: an explorative study of the professional socialization and management of colleagues with substance use disorders Leah Svingen · Rita E. Dykstra · Jamie L. Simpson · Anna E. Jaffe · Rick A. Bevins · Gustavo Carlo · David DiLillo · Kathleen M. Grant · Kathleen M. Grant
Cigarette Smoking Reduction in Pregnant Women With Opioid Use Disorder Marija Zeremski · Roberto Zavala · Rositsa B. Dimova · Yang Chen · Steven Kritz · Clewert Sylvester · Lawrence S. Brown · Andrew H. Talal · Andrew H. Talal
Improvements in HCV-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention Erik W. Gunderson · Michael Sumner · Michael Sumner
The Effect of Co-occurring Substance Use on Gamma-hydroxybutyric Acid Withdrawal Syndrome Caspersen S · Tau Gz · Ammerman S · Ammerman S
The Prevalence of Substance Use and Other Mental Health Concerns Among American Attorneys Seth Ammerman · Gregory Tau · Gregory Tau
Weeding Out the Truth: Adolescents and Cannabis Medhat M. Bassiony · Usama M. Youssif · Ramadan A. Hussein · Mervat Saeed · Mervat Saeed
Psychiatric Comorbidity Among Egyptian Patients With Opioid Use Disorders Attributed to Tramadol Jamie K. Lim · Jeffrey P. Bratberg · Corey S. Davis · Traci C. Green · Alexander Y. Walley · Alexander Y. Walley
Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists Rama M. Kamal · B.A.G. Dijkstra · Antonius Loonen · Cornelis Aj De Jong · Cornelis Aj De Jong
Weeding Out the Truth: Adolescents and Cannabis: Case and Discussion John J. McCarthy · John J. McCarthy
Methadone and Buprenorphine for Opioid Dependence During Pregnancy: A Retrospective Cohort Study: Re: Meyer et al Larissa Mooney · Maureen Hillhouse · Christie Thomas · Alfonso Ang · Gaurav Sharma · Garth Terry · Linda Chang · Robrina Walker · Madhukar H. Trivedi · David Croteau · Steven Sparenborg · Walter Ling · Walter Ling
Cigarette Smokers are Less Likely to Have Undetectable Viral Loads: Results From Four HIV Clinics Karen L. Cropsey · James H. Willig · Michael J. Mugavero · Heidi M. Crane · Cheryl McCullumsmith · Sarah T. Lawrence · James L. Raper · W. Christopher Mathews · Stephen Boswell · Mari M. Kitahata · Joseph E. Schumacher · Michael S. Saag · Michael S. Saag
Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder Johanne Korsdal Srensen · Anette Fischer Pedersen · Peter Vedsted · Niels Henrik Bruun · Bo Christensen · Bo Christensen
Two Case Reports on Use of Prazosin for Drug Dreams James Schuster · David Loveland · Meghna Parthasarathy · Nicole Maiolo · Alyssa Cilia · Kim Castelnovo · Kim Castelnovo
The impact of sex upon needs and quality of life within a population on methadone treatment Patricia Byrne · Kevin Ducray · Bobby P Smyth · Bobby P Smyth
Abuse Potential of Oral Phendimetrazine in Cocaine-dependent Individuals: Implications for Agonist-like Replacement Therapy Bolin Bl · William W. Stoops · Sites Jp · Craig R. Rush · Craig R. Rush
Strategic Versus Nonstrategic Gambling: Results From a Community Survey Mythily Subramaniam · Edimansyah Abdin · Janhavi Ajit Vaingankar · Shazana Shahwan · Louisa Picco · Siow Ann Chong · Siow Ann Chong
Neonatal abstinence syndrome: Presentation and treatment considerations Hendrée E. Jones · Karol Kaltenbach · Elisabeth Johnson · Carl Seashore · Emily Freeman · Erin Malloy · Erin Malloy
What do we know now about the impact of the laws related to marijuana Jane Carlisle Maxwell · Bruce Mendelson · Bruce Mendelson
Assessing the validity of online drug forums as a source for estimating demographic and temporal trends in drug use Igor Elman · Jacob Borodovsky · Margaret Howard · Arielle Scoglio · Jackson Steinkamp · Amy Sobieszczyk · David Mysels · Mark J. Albanese · Mark J. Albanese
A Systematic Review on the Use of Psychosocial Interventions in Conjunction with Medications for the Treatment of Opioid Addiction Karen L. Dugosh · Amanda J. Abraham · Brittany Seymour · Keli McLoyd · Mady Chalk · David S. Festinger · David S. Festinger
Tobacco Use Disorder: A Family Disease DiFranza · Bhuvaneswar C · Jolicoeur D · Susanne E. Tanski · Jonathan P. Winickoff · Jonathan P. Winickoff
Reproductive Health Needs Among Substance Use Disorder Treatment Clients Mishka Terplan · Maayan Lawental · Melanie Bryant Connah · Caitlin E. Martin · Caitlin E. Martin
Probing the Serotonin Transporter Availability among Male Cigarette Smokers: A SPECT Study with [ 123I] ADAM Rong Jiang Zhao · Shih Hsien Lin · Lan Ting Lee · I. Hui Lee · Po See Chen · Kao Chin Chen · Yen Kuang Yang · Yen Kuang Yang
Opioid and Benzodiazepine Withdrawal Syndrome in PICU Patients: Which Risk Factors Matter? da Silva Ps · Reis Me · Fonseca Ts · Fonseca Mc · Fonseca Mc
Using a Learning Collaborative Strategy With Office-based Practices to Increase Access and Improve Quality of Care for Patients With Opioid Use Disorders Benjamin R. Nordstrom · Elizabeth C. Saunders · Bethany McLeman · Andrea Meier · Haiyi Xie · Chantal Lambert-Harris · Beth Tanzman · John Brooklyn · Gregory King · Nels Kloster · Clifton Frederick Lord · William Roberts · Mark P. McGovern · Mark P. McGovern
International Statement Recommending Against the Use of Terminology That Can Stigmatize People Richard Saitz · Richard Saitz
Are We Growing Psychotropics in Our Backyards?: A Case Report and Literature Review of Coleus blumei Nitin Chopra · Lon Hays · Lon Hays
The Authors Reply to Cannabis Use Disorders and ADHD Zaman T · Boyd Jw · Boyd Jw
Controlled Substances and Prescribers Daniel Tyler Bouland · David Withers · David Withers
Cannabis Use Disorders and ADHD Peter A. DeMaria · Peter A. DeMaria
Sources of Prescription Opioids for Nonmedical Use Karsten Bartels · Ingrid A. Binswanger · Christian J. Hopfer · Christian J. Hopfer
Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence Sabrina Poole · Anna Pecoraro · Geetha Subramaniam · George E. Woody · Victoria L. Vetter · Victoria L. Vetter
Associations between family history of substance use, childhood trauma, and age of first drug use in persons with methamphetamine dependence Michael J. Paul · Margaret S. Chisolm · Matthew W. Johnson · Ryan Vandrey · Mark Dredze · Mark Dredze
Commentary on Zeremski et al. (2016): Improvements in Hcv-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention Samuel B. Holzman · Darius A. Rastegar · Darius A. Rastegar
Co-occurring Disordered Gambling among Treatment-Seekers at a Community Outpatient Addiction Clinic Teerayuth Rungnirundorn · Viroj Verachai · Joel Gelernter · Robert T. Malison · Rasmon Kalayasiri · Rasmon Kalayasiri
An Argument for Change in Tobacco Treatment Options Guided by the ASAM Criteria for Patient Placement He Zhu · Li-Tzy Wu · Li-Tzy Wu
Understanding risk factors for opioid overdose in clinical populations to inform treatment and policy Adam Rzetelny · Barbara Zeller · Nicholas Miller · Kenneth L. Kirsh · Steven D. Passik · Steven D. Passik
Definitive LC-MS/MS Drug Monitoring Impacts Substance-use Treatment Planning and Patient Outcomes: A Brief Report Marija Zeremski · Clewert Sylvester · Andrew H. Talal · Andrew H. Talal
Response to Commentary on Zeremski et al. (2016): Improvements in HCV-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention Geoff McCombe · Anne Marie Henihan · Dorothy Leahy · Jan Klimas · John S. Lambert · Walter Cullen · Walter Cullen
AST: A Simplified 3-item Tool for Managing Alcohol Withdrawal Terril L. Verplaetse · Brian Pittman · Julia M. Shi · Jeanette M. Tetrault · Sabrina Coppola · Sherry A. McKee · Sherry A. McKee
Effect of Lowering the Dose of Varenicline on Alcohol Self-administration in Drinkers With Alcohol Use Disorders Jennifer M. Mitchell · Peter A. Arcuni · Dawn Weinstein · Josh Woolley · Josh Woolley
Intranasal Oxytocin Selectively Modulates Social Perception, Craving, and Approach Behavior in Subjects With Alcohol Use Disorder Robert C. Sherrick · Robert C. Sherrick
Measuring Quality of Buprenorphine Care Robertas Badaras · Tomas Jovaiša · Sarunas Judickas · Juozas Ivaskevicius · Juozas Ivaskevicius
Changes in Potassium Concentration During Opioid Antagonist Induction: Comparison of Two Randomized Clinical Trials Robert G. Newman · Susan G. Gevertz · Susan G. Gevertz
Stigmatizing and Misleading Terminology-More Andrew J. Saxon · Elinore F. McCance-Katz · Elinore F. McCance-Katz
Some additional considerations regarding the American society of addiction medicine national practice guideline for the use of medications in the treatment of addiction involving opioid use Adam J. Gordon · Wei-Hsuan Lo-Ciganic · Gerald Cochran · Terri Cathers · Julie M. Donohue · Julie M. Donohue
Treatment Quality for Buprenorphine Care: The Pot at the End of the Rainbow Jose M. Trigo · Alexandra Soliman · Gregory Staios · Lena Quilty · Benedikt Fischer · Tony P. George · Jürgen Rehm · Peter Selby · Allan J. Barnes · Marilyn A. Huestis · Bernard Le Foll · Bernard Le Foll
Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series Joni Bing Fei Teoh · Anne Yee · Mahmoud Danaee · Chong Guan Ng · Ahmad Hatim Sulaiman · Ahmad Hatim Sulaiman
Under-reporting of risky drug use among primary care patients in federally qualified health centers Sarah E. Wakeman · Genevieve Pham Kanter · Karen Donelan · Karen Donelan
Guidelines and Quality Measures Should Reflect Evidence for Effectiveness of Naltrexone Alex H. S. Harris · Cheng Chen · Constance Weisner · Mady Chalk · Victor Capoccia · Cindy Parks Thomas · Cindy Parks Thomas
Response to Dr Fiscella: Transparency and Debate are Essential to Improve Guidelines and Measures He Zhu · Li-Tzy Wu · Li-Tzy Wu
Implementation of Motivational Interviewing in Substance Use Disorder Treatment: Research Network Participation and Organizational Compatibility Amber L. Bahorik · Derek D. Satre · Andrea H. Kline-Simon · Constance Weisner · Cynthia I. Campbell · Cynthia I. Campbell
Energy Drink Consumption and Cardiac Complications: A Case for Caution Traci Rieckmann · Amanda J. Abraham · Brian E. Bride · Brian E. Bride
Response to Schwartz Commentary on Dugosh et al Maryam Sattari · Anahita Sattari · Amir Kazory · Amir Kazory
The difference between random and postaccident urine drug test concentrations among Southern Indiana, Western Kentucky, and Eastern Illinois workers Natasha Simonovska · Beti Zafirova-Ivanovska · Aleksandra Babulovska · Zanina Pereska · Irena Jurukov · Liljana Trenchevska-Siljanovska · Liljana Trenchevska-Siljanovska
Trends and Correlates of Cannabis-involved Emergency Department Visits: 2004 to 2011 Julie R. Gaither · Joseph L. Goulet · William C. Becker · Stephen Crystal · E. Jennifer Edelman · Kirsha Gordon · Robert D. Kerns · David Rimland · Melissa Skanderson · Amy C. Justice · David A. Fiellin · David A. Fiellin
The Effect of Substance Use Disorders on the Association Between Guideline-concordant Long-term Opioid Therapy and All-cause Mortality Olena Zhabenko · Elizabeth Austic · Deirdre A. Conroy · Peter F. Ehrlich · Vijay Singh · Quyen Epstein-Ngo · Rebecca M. Cunningham · Maureen A. Walton · Maureen A. Walton
Substance Use as a Risk Factor for Sleep Problems Among Adolescents Presenting to the Emergency Department Matthew C. Waesche · Clark Cb · Karen L. Cropsey · Karen L. Cropsey
The connection between thwarted belongingness, alcohol consumption, suicidal, and homicidal ideation in a criminal justice sample Paul F. Velleman · Ann C. Lapinski · Ann C. Lapinski
Statistics Failures Make Lawyer Addiction Estimates Worthless Michael J. Mason · Gregory J. Golladay · William A. Jiranek · Brian Cameron · Joel J. Silverman · Nikola Zaharakis · Paul Plonski · Paul Plonski
Depression Moderates the Relationship Between Pain and the Nonmedical Use of Opioid Medication Among Adult Outpatients James W. Price · James W. Price
Influence of Duration of Heroin Dependence on Humoral Immunologic Indicators Jan Gryczynski · Kevin E. O’Grady · Shannon Gwin Mitchell · Steven J. Ondersma · Robert P. Schwartz · Robert P. Schwartz
Sex Differences in the Association Between Internalizing Symptoms and Craving in Methamphetamine Users Karen L. Dugosh · Amanda J. Abraham · David S. Festinger · David S. Festinger
Immediate Versus Delayed Computerized Brief Intervention for Illicit Drug Misuse Declan T. Barry · Tera L. Fazzino · Emily Necrason · Joel Ginn · Lynn E. Fiellin · David A. Fiellin · Brent A. Moore · Brent A. Moore
The Availability of Ancillary Counseling in the Practices of Physicians Prescribing Buprenorphine Robert P. Schwartz · Robert P. Schwartz
When Added to Opioid Agonist Treatment, Psychosocial Interventions do not Further Reduce the Use of Illicit Opioids: A Comment on Dugosh et al Patrick R. Krill · Patrick R. Krill
Authorʼs Response to Statistics Failures Make Lawyer Addiction Estimates Worthless Lewei Allison Lin · Avinash Hosanagar · Tae Woo Park · Amy S.B. Bohnert · Amy S.B. Bohnert
Opioid Overdose: Risk Assessment and Mitigation in Outpatient Treatment Kelly E. Dunn · Frederick S. Barrett · Claudia Yepez-Laubach · Andrew C. Meyer · Bryce Hruska · Stacey C. Sigmon · Michael Fingerhood · George E. Bigelow · George E. Bigelow
Brief Opioid Overdose Knowledge (BOOK): A Questionnaire to Assess Overdose Knowledge in Individuals Who Use Illicit or Prescribed Opioids Emily E. Hartwell · Nathasha R. Moallem · Kelly E. Courtney · Suzette Glasner-Edwards · Lara A. Ray · Lara A. Ray
Predictors of Poor Adherence to Methadone Maintenance Treatment in Yunnan Province, China Jiucheng Shen · Mei Wang · Xiaodan Wang · Guanbai Zhang · Jie Guo · Xinyue Li · Jianhua Li · Jianhua Li

Predictors of Leaving an Inpatient Medical Withdrawal Service Against Medical Advice: A Retrospective Analysis
Journal of Addiction Medicine | 2018
Hannah K. Knudsen · Michelle R. Lofwall · Sharon L. Walsh · Jennifer R. Havens · Jamie L. Studts · Jamie L. Studts
Does Medical Cannabis Use Increase or Decrease the Use of Opioid Analgesics and Other Prescription Drugs
Journal of Addiction Medicine | 2018
Larry F. Chu · John Sun · Anna Clemenson · Matthew J. Erlendson · Tom Rico · Erika Cornell · Hannah Obasi · Zahra N. Sayyid · Ellen M. Encisco · Jeff Yu · Jamison G. Gamble · J. David Clark · J. David Clark
Reply to Dr Peltz
Journal of Addiction Medicine | 2018
Alicia M. Allen · Samantha Carlson · Tyler A. Bosch · Lynn E. Eberly · Kola Okuyemi · Uma S. Nair · Judith S. Gordon · Judith S. Gordon